A double arm, cross-over trial comparing rectal mucosal 5-aminosalicylate concentrations in ulcerative colitis patients taking pH-dependant release and azo-bonded formulations

  • Gibson, Peter (Primary Chief Investigator (PCI))
  • Gearry, Richard (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/06 → 31/10/07

Funding

  • Fresenius Kabi Australia Pty Limited: A$60,000.00